The groundbreaking therapy of the medication represents a major advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide378136.blogspothub.com/40777672/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment